Surrey students offered meningitis B jab after undergraduate"s death

Students living on campus at the University of Surrey are being offered the meningitis B vaccine after a student died and two others were taken to hospital with the bug.

John Igboanugo, a first-year physics undergraduate, died earlier this month following a sports trip to Rimini in Italy.

Two other Surrey students also fell ill with meningitis but have now been discharged from hospital.

Public Health England (PHE) said laboratory reports had confirmed two of the students had meningitis B while the third was thought to have contracted the B strain of the bug as well.

About 4,200 full-time students living in halls on the Guildford campus – around a third of the total student population – are now being offered the jab to protect against meningitis B.

The vaccine is normally only routinely given on the NHS to young babies.

Prof Max Lu, vice-chancellor of the University of Surrey, said: “We are greatly saddened by the death of our student, and our hearts go out to his family and friends during what continues to be a very difficult time.

“The health and wellbeing of everyone on campus is of the utmost importance.

“We are working closely with PHE on a targeted vaccination programme and are reassured that the risk to staff, students and visitors is still very low.”

Prof Kamila Hawthorne, associate dean for medicine at the University of Surrey, added: “We appreciate that when cases of meningitis B occur there is increased concern about the potential spread, but evidence shows that meningococcal infection is not highly contagious, comparatively rare and the risk to the wider community remains very low.

“Only people who have prolonged, close contact with an ill person are at a slightly increased risk of becoming unwell.

“If anyone is in any doubt or concerned about their health, or the health of others, please call NHS 111 urgently.”

The university said there was no direct link between the three cases.

The two students who were taken to hospital had not been on the sports trip to Italy.

PHE said passengers on the coach trip had been offered antibiotics as a precaution.

It said the wider population in the town and non-students who visited but did not live on the university campus were not considered to be within the at-risk group.

Dr Peter English, consultant in communicable disease control from PHE in the south-east of England, said: “Meningococcal infection is comparatively rare and the risk of transmission is relatively low.

“People who have prolonged, close contact with an ill person are at a slightly increased risk of becoming unwell in the following days.

“This is why immediate contacts of the cases have already been offered antibiotics as a precautionary measure.

“After considering the medical evidence, we have decided to offer vaccination to around 4,200 students living in halls of residence at the university to reduce risk of further cases next term.

“I would like to reassure other students, teachers, their families and the local community that the risk of catching this infection remains very low, and any higher risk is confined to those being offered the vaccine.”

Students are regularly offered a vaccine against other strains of meningitis, known as the Men ACWY jab.

Meningitis can develop rapidly and is sometimes mistaken for flu. Those who survive can be left with life-changing disabilities.

Symptoms include a high temperature, feeling or being sick, exhaustion and irritability, a headache and aching joints, stiff neck and dislike of bright lights, confusion and a rash.

Surrey students offered meningitis B jab after undergraduate"s death

Father of meningitis death girl accuses government of complacency

A man whose daughter’s death from meningitis sparked a nationwide petition for more children to be vaccinated against it has accused the government of complacency.

On the first anniversary of Faye Burdett’s death, her father, Neil said the government has done “absolutely nothing” to raise awareness of the disease, despite promises to do so.

He also revealed that two-year-old Faye – who fought meningitis B for 11 days – mouthed the word “mummy” just before she died.

Burdett and his wife, Jenny,, made the decision to turn off Faye’s life support last Valentine’s Day after her body was ravaged by sepsis caused by meningitis. They released photos of their dying daughter covered in a rash, prompting more than 820,000 people to sign a petition for the meningitis B jab Bexsero to be given to all children.

The government has since declined to make the vaccine more widely available, saying it is not a good use of money. Ministers have yet to release calculations on how vaccines are deemed to be affordable and have not launched a meningitis awareness campaign, promised by a former public health minister.

Burdett said the decision not to extend the vaccine to more age groups was “insulting and devastating”. He said he has heard nothing since appearing before MPs on the petitions committee last March. “Children under five are vulnerable to meningitis and they can’t tell you exactly what is happening,” he said. “They are solely reliant on their parents and carers to spot that something is wrong.

“We have been through something so terrible and we thought if we could stop it happening to other families, that’s what we wanted to do. But since going to parliament, we’ve heard nothing.

“If nobody in parliament is going to take any notice and do something, who else is there? The government is being complacent and we feel badly let down. There is just this massive hole that children are falling into.

“We feel like we were ushered out of the building and that was that. It’s all been brushed under the carpet. The MPs there said they would keep pushing for an awareness campaign but we’ve heard nothing, not even from our own MP. It’s not acceptable and it’s not fair because children are still dying.”

Faye’s meningitis was initially mistaken for a virus: she was sent home from Maidstone hospital but returned seven hours later.

Burdett, 38, said an investigation was still ongoing into what happened at the hospital but he is critical of the process in which hospitals carry out their own investigations when things go wrong. “This is a process where people are investigating themselves. The hospital is judging itself,” he said. “This needs to be an outside, independent process.”

Asked how he and his wife were coping, he said: “I don’t think it ever gets any better. You learn to cope, you learn that you can do crazy things or push the self-destruct button, but none of that is going to bring Faye back.

“Every day we miss her, we talk about her. There’s a huge hole in our lives that is never going to be filled. But we’re also proud of her – because of the petition and because for 11 days she fought meningitis against the odds. That shows her strength and her fight.”

Burdett, a lorry driver, and his wife Jenny, 36, a beautician, spent every day at Faye’s hospital bedside. “She could hear and she could react,” he said. “Every morning I would sit with her and she would squeeze my finger.

“Once, she opened her eyes and she looked around. She mouthed the word ‘mummy’. We never heard her voice again because of the ventilator.”

Doctors told them Faye’s chance of survival was minimal. The couple had already signed forms consenting to the amputation of both Faye’s legs at the hips, one complete arm and the other arm just below the elbow. “There was also the internal damage that sepsis had done,” Burdett said. “Her kidneys weren’t working and the list went on and on. Turning off the machine was the hardest decision we have ever had to make but it was the right thing to do. We’ve never regretted that decision.”

Faye Burdett before (left) and after she contracted meningitis. Photograph: Meningitis Now/PA

The Burdetts plan to spend the anniversary of Faye’s death quietly at home in Maidstone, Kent. “We will go and visit her gravestone and take flowers,” Burdett said. “We will light a candle for her as we do every night.

“Faye was a very happy girl who loved to run around. She loved painting and was very clever for her age, she was so bright and determined.

“Faye loved curry. I would make her chicken tikka masala and she loved it. She was such a happy little girl but that’s the thing with meningitis – in the click of a finger, it all changes.”

Burdett warned other parents not to give their child ibuprofen or paracetamol before taking them to the hospital or GP. The couple gave Faye ibuprofen, which they believe masked some of her symptoms.

Last April, Jane Ellison, then public health minister, pledged to launch an awareness campaign for parents on the signs of meningitis and the government agreed to release its cost-modelling for vaccines. There is concern that the current model does not adequately account for the lifetime costs of caring with somebody left disabled by meningitis.

Bexsero is available on the NHS for babies aged two months, followed by a second dose at four months and a booster at 12 months. Parents who wish to have older children vaccinated must pay privately. Burdett said the government had promised to include a page on meningitis symptoms in the red book given to the parents of newborns, but this had also not yet been done.

A Department of Health spokesman said: “The UK is the first country in the world to have introduced a national Men B vaccination programme using Bexsero. We have made important progress, vaccinating more than one million babies since September 2015, in which time the number of cases in infants aged one and under has dropped by 50%.”

Public Health England has launched a separate campaign on sepsis. The charity Meningitis Research Foundation estimates that 400 cases of meningitis B among children up to the age of five could have been prevented if they had been given access to the vaccine.

Father of meningitis death girl accuses government of complacency

Young people urged to get vaccinated against aggressive meningitis W

Students and other young people are being urged to get vaccinated against an aggressive strain of meningitis that killed 24 people in the last year for which there are figures.

Public Health England (PHE) said cases of meningitis W, which can cause life-changing disabilities and kills one in 10 who contract it, were on the rise. It is one of the most aggressive and dangerous forms of the disease. In 2009 there were 22 cases in England, but in the last year there have been more than 200.

Young people going to university are at particular risk because they mix with so many new people, some of whom may be carrying the meningococcal bacteria that cause meningitis W and septicaemia or blood poisoning.

PHE urged them to be immunised with a new vaccine, introduced last year, which protects against four strains of the bacterial infection – A, C, Y and W.

Related: New meningitis vaccine to be offered to UK teenagers and students

Between 2009 and 2012, there were just four deaths from meningitis W, but in 2013-14, the last year for which figures are available, the figure rose to 24. For the first time in a decade, babies and toddlers were among those who died. As other strains have become less of a problem, meningitis W now accounts for a quarter of all meningitis infections.

“Since 2009, there has been a rapid increase in cases of Men W across England, with students particularly at risk,” said Dr Mary Ramsay, the head of immunisation at PHE. “Protecting young people from this potentially deadly disease as they embark upon one of the most important periods of their lives is vitally important. The vaccination will save lives and prevent lifelong devastating disability.

“We are encouraging all eligible 17 and 18-year-olds who have just left school to get vaccinated, particularly those heading to college or university. Young people and those around them should be alert to the signs and symptoms of meningitis and septicaemia. Get vaccinated as soon as possible, remain vigilant and seek urgent medical help if you have concerns for yourself or friends.”

Meningococcal bacteria live in the back of the nose and throat in about one in 10 of the population without causing any illness. The bacteria is spread from person to person by close contact with a person carrying the bacteria, such as coughing, kissing and sneezing.

All meningococcal bacteria can cause meningitis and septicaemia, but meningitis W can also cause other illnesses such as pneumonia and joint infections. The early symptoms are headache, vomiting, muscle pain, fever and cold hands and feet.

GPs have been asked to call in young people up to the age of 25 for vaccination. Universities have also been asked to urge students who have not been vaccinated at home to get the jab locally.

Related: Meningitis B petition now most signed in parliamentary history

Meningitis charities are also sounding the alarm. “Up to a quarter of students carry the bacteria that can cause meningitis compared to one in ten of the general population. In the UK every university could experience at least one case of meningitis amongst its students within the first term,” said Liz Brown, the chief executive of Meningitis Now.

“It’s vital that those going to Uni this autumn are not complacent about the threat of meningitis. We urge them to take up this lifesaving vaccine before they go.”

Vinny Smith, the chief executive of the Meningitis Research Foundation, said: “We’re encouraging students going to uni for the first time to do something great today. By getting this free meningitis vaccine from your GP you’re not only protecting yourself from a potentially deadly disease, but also protecting others by stopping the spread.

“It’s also vital to watch out for your friends if they’re unwell. If people do have meningitis it can be like a very bad hangover that quickly gets worse. It can be deadly, so act fast and get medical help.”

Young people urged to get vaccinated against aggressive meningitis W

Three Scottish scouts taken care of for meningitis soon after Japan trip

The Scottish well being authorities have contacted about 4,000 British scouts who took part in a jamboree in Japan following 3 from the north of Scotland required therapy for meningitis.

The precautionary letter from Overall health Protection Scotland mentioned whilst the danger of an additional case was very slight, it was sensible to be aware of the signs and symptoms, which incorporate vomiting, serious headache, stiff neck and seizures.

The HPS letter, dated 14 August, mentioned the 3 Scottish scouts were recovering nicely after currently being treated with antibiotics.

Jim McMenamin, a advisor epidemiologist, wrote: “I value this news may possibly lead to some anxiety but please be reassured that as a result far no other cases have been reported from scouts from other elements of the Uk or from other international nations attending the jamboree. The occurrence of this sickness is unusual and the danger of one more case amongst individuals attending the jamboree is quite small.”

Even so, the Associated Press reported that Sweden’s public well being company explained on Monday that one particular Swedish participant was most likely to have contracted the condition at the jamboree, and that two other cases had been below investigation.

An estimated thirty,000 scouts from around the world attended the 12-day event that ended on 8 August in Kirarahama in western Japan, like 4,000 from Britain. The jamboree incorporated a go to to the Hiroshima Peace Memorial Museum as portion of the 70th anniversary of a nuclear bomb being dropped on the city.

In his letter, McMenamin stated not all of indicators and symptoms of meningitis might demonstrate at once, but somebody with the sickness could grow to be really ill. The sickness might progress in excess of one or two days, but can develop really quickly, occasionally in a matter of hrs.

Meningitis, an infection of the meninges (protective membranes that surround the brain and spinal cord), can be caused by bacteria or a virus. It leads to the meninges turning into swollen, which can harm the nerves and brain. The early signs can be like poor flu, but diagnosis in the early phases can be difficult.

McMenamin mentioned laboratory and other data indicated that the chance of infection appeared confined to the little group of scouts in the north of Scotland who attended the jamboree and individuals in households of the 3 confirmed instances.

Three Scottish scouts taken care of for meningitis soon after Japan trip

Meningitis C vaccine shortage prompts fears of key outbreak in Africa

A shortage of meningitis C vaccine is threatening to jeopardise the potential to cope with a likely outbreak of the condition in Africa, global public well being organisations, such as the World Overall health Organisation, have warned.

A Meningitis A vaccine launched in 2010, MenAfriVac, has substantially lowered incidence of that strain but type C infections have been growing and a cheap equivalent that would shield against meningitis C, between other strains, is still many years away.

In the meantime, the members of the Global Coordinating Group for Vaccine Provision for Epidemic Meningitis Handle, which also comprises the Worldwide Federation of Red Cross and Red Crescent Societies (IFRC), and Médecins sans Frontières (MSF) are attractive to pharmaceutical firms to support them by plugging the gap.

Related: Meningitis vaccine withstands African heat with no injury

At existing, they say pharmaceutical businesses have advised them they are unable to provide the newer, a lot more efficient conjugate vaccines, which supply longer lasting immunisation than the outdated polysaccharide vaccines.

Dr William Perea, coordinator of the management of epidemic ailments unit at WHO, explained: “The issue is that now that we have vaccinated 200 million folks there are no far more epidemics with [meningitis] A, but this 12 months was a shock to us because we had been not expecting such a large one particular [meningitis C epidemic] as occurred in Niger.

“What we have told the companies is we want the conjugate vaccine to be ready to prevent epidemics for longer periods but they will not make the vaccine in ample quantities at affordable costs.”

As nicely as the further safety afforded by the conjugate vaccines, they are also ideal for kids, in contrast to the polysaccharide version. Even so, according to WHO figures, they usually value at least ten occasions far more than polysaccharide vaccines, which are priced at about $ 4 to $ five. Even with the producers providing the conjugate vaccines at $ 25 a dose, for the five million doses needed that amounts to $ 125m as opposed to $ 25m for the polysaccharide vaccines.

Folks collect at the well being clinic in Lazaret, near Niamey, Niger, in April 2015, the place sufferers struggling from meningitis are being treated. Photograph: Boureima Hama/AFP/Getty

“Either they assist us have affordable conjugate vaccines or we’ll have to use an previous vaccine that does not supply us with the identical quality,” mentioned Perea.

Meningitis C can trigger serious brain injury and is fatal in 50% of cases if untreated.

There were twelve,000 circumstances of meningitis in Niger and Nigeria and 800 deaths in the very first 6 months of the 12 months but with cases increasing because 2013, the fear is that subsequent year’s meningitis season, which starts in January, could see a considerably larger quantity of instances.

The MenAfriVac stockpile, brought about by way of a public-private partnership, was produced in response to an outbreak of meningitis A in sub-Saharan Africa in 1996-97 that developed 200,000 situations and 20,000 deaths.

It is as well early to say whether or not the C strain will behave in a similar style to A, moving to other nations in sub-Saharan Africa, but Perera mentioned the fact that it had already expanded from Nigeria to Niger in a couple of many years meant that this was a situation it was crucial to put together for.

MSF’s global healthcare coordinator, Dr Myriam Henkens, emphasised the importance of a multivalent vaccine – one particular that covers distinct strains of the illness: “We want vaccine makers to prepare manufacturing of a multivalent vaccine now to let ample lead time and capacity to meet this demand.”

A GSK spokeswoman confirmed the business had been in talks with the WHO and mentioned: “We are evaluating if and how we may possibly be in a position to supply further doses.”

Sanofi Pasteur said it was trying to improve production of its polysaccharide vaccine which covers Meningitis C.

Meningitis C vaccine shortage prompts fears of key outbreak in Africa

Meningitis B Vaccine: Is It For You?

In February 2013 school student Emily Stillman died of meningitis. She was nicely-liked, smart, and wholesome. And she had acquired her meningitis vaccine. What went incorrect?

Meningitis is an infection of the membranes that line the brain and spinal cord. It can begin with cold-like signs and symptoms but it’s usual signs and symptoms are headache, stiff neck, fever, and at times a splotchy rash. Even if handled properly, it often leads to extended-phrase well being troubles, and is too-often fatal. Simply because of this, prevention has been an important public overall health goal.

In the U.S., we’ve completed a excellent task of stopping meningitis. Three of the most essential bacteria that result in the ailment now have powerful vaccines.

Haemophilus influenzae type b (Hib) was a very widespread cause of childhood illnesses, like ear infections. It was a typical cause of epiglottitis, a disease that could quickly suffocate a younger little one. It also causes meningitis. As a medical pupil, we had been instilled with a healthier respect for the ailment. We realized the indicators of epiglottitis, its look on X-ray. But we did not see that several circumstances. Because the introduction of the vaccine in the late 1980s, the incidence of significant illness due to Hib has dropped 99%.

Streptococcus pneumoniae (pneumococcus sorry, no better nickname available) is a frequent lead to of pneumonia, and like Hib, it can trigger ear infections in youngsters. It can also lead to meningitis. Before the broad use of the vaccine, about 200 kids died every 12 months of pneumococcus infections, including meningitis. Schedule vaccination has led to a 99% lessen in severe pneumococcal ailment in children.

The “classic” kind of meningitis is brought on by Neisseria meningitidis (meningococcus also no good nickname). This is a bacteria that lives harmlessly in many men and women, but under the correct conditions can migrate into the lining of the brain creating a devastating condition. Our achievement with vaccination against this disease has been a bit much more complicated than with the other two. There are numerous diverse kinds of this bacterium, recognized by a capital letter. The most widespread in the US are B, Y, C, W-135. Vaccination against Y, C, and W is has been very effective. In the US, kind B is unusual right after infancy, and no vaccine is offered.  This is the sort that killed Emily.

Emily’s case probably occurred outside of an outbreak, as most cases do. There have been, nonetheless, two outbreaks of variety B on university campuses recently, at Princeton and at University of California Santa Barbara. The FDA and CDC allowed the use of a variety B vaccine in these outbreaks, but this vaccine hasn’t been accepted in the US. It has been utilised safely for years in Europe and Canada.

Meningitis caused by type B meningococcus is nevertheless quite uncommon, and rarer still in outbreaks, but mothers and fathers of kids heading off to university are anxious, if my telephone line is any indication. Households here, near the Canadian border, have crossed the bridge to get their little ones vaccinated, often in organized groups. I’m typically asked if this is a very good concept.

The absolute danger of a college-age child dying from meningitis is extremely, quite small. If it’s your child however, that’s tiny comfort. I can’t tell my patients if they need to get a vaccine that hasn’t been accepted. Unapproved drugs have caused all kinds of troubles above the years. But European and Canadian equivalents of the FDA are rather great. It would seem very likely that a type B vaccine will be authorized for use in the US at some level, but until then, I haven’t discouraged anyone from heading over the border to get one particular.

As constantly, this site is not providing specific health care tips but just exploring an important concern. Before employing any medications or acquiring any vaccines, you need to consult with your doctor. 

Meningitis B Vaccine: Is It For You?

Three-week-previous woman virtually killed by meningitis from loved ones cat

The promotions assistant of Winsham, Somerset, mentioned: “It seemed this kind of an unlikely lead to.

“The medical professionals mentioned she was only the 39th man or woman in the world identified to picked up that distinct strain of meningitis.

“She was just 3 weeks outdated and extremely vulnerable. It was unreal and quite scary also.

“Chesney even now lives with my mum and there’s no danger to be concerned about any more from them being in speak to. In reality they follow every other all around all the time when we pay a visit to.”

Miss Dodd mentioned alarm bells started out ringing when Sparkle would not quit crying when she was three weeks old.

She explained: “I tried everything to calm her down, but she wouldn’t cease yelling. She was extremely hot and negative-tempered.

“After a handful of hrs I decided to trust my mothers’ instinct and consider her her to hospital.”

At Musgrove Park hospital, medical doctors took her daughter away for some emergency exams.

She stated: “It broke my heart to see her hooked up to so a lot of wires. When they told me she had meningitis, I felt sick.

“It did not make any sense – Sparkle didn’t have a rash and I hadn’t observed her shying away from vivid lights. She had an really unusual kind – there had been just 39 situations previously, which actually took me by shock.

“I was advised that she could have died inside hours if I hadn’t brought her in.”

Medical professionals traced the supply of the meningitis to Chesney.

Miss Dodd mentioned: “They believed that it was transferred via Chesney’s saliva. I’d been mindful not to depart them alone together, but Chesney have to have licked Sparkle’s milk bottle whilst my back was turned.

“I was consumed with guilt – I felt as if I hadn’t stored a mindful ample eye on issues, and that Sparkle’s sickness was all my fault. I sent Chesney to go and dwell with my mom.”

Soon after a month in hospital, Sparkle came home and has because gone on to make a complete recovery. She is right now a content, healthy toddler who is unafraid of animals.

Miss Dodd said: “I’ve been advised it’s properly secure for Sparkle to devote time with Chesney, which is a relief because they’ve truly become very best buddies.”

Nowadays, Miss Dodd is keen to advise new dad and mom to investigation early signs of meningitis in children, which contain soreness, mottled skin and unusually cold hands and feet or shivering.

She said: “I did not know quite considerably about meningitis – I usually believed the only factor I should be concerned about was a rash. But there are plenty of other signs also, and realizing them can make all the variation in helping to catch it early.

“I try not to believe about how close I came to dropping Sparkle. I am so grateful that she’s all appropriate now.”

Three-week-previous woman virtually killed by meningitis from loved ones cat

Sahel meningitis outbreaks linked to wind and dust ranges, declare scientists

A donkey throws up dust in Chad’s Mao area. Research suggests wind and dust levels can be employed to predict meningitis. Photograph: Rebecca Blackwell/AP

Scientists could soon be in a position to forecast ailment outbreaks in sub-Saharan African’s “meningitis belt” using climate information. The forecasts could be used to strategy early vaccination drives aimed at preventing or limiting casualties.

In the “meningitis belt” of sub-Saharan Africa, which stretches across the Sahel from Senegal to Ethiopia, major epidemics of lethal meningitis are schedule. A devastating 1996-97 outbreak killed about 25,000 individuals.

An powerful new vaccine has driven a decrease in meningitis, but the common method in the area has been to carry out vaccination drives and antibiotic therapy of the condition in districts previously struggling outbreaks. In some cases, assist arrives as well late to make a substantial influence, overall health officials say.

In the close to future, although, scientists may well be ready to use climate factors this kind of as wind and dust circumstances to forecast these epidemics and develop earlier vaccination methods to prevent or limit casualties.

New research carried out in Niger by the Nasa Goddard Institute for Room Research and Columbia University’s Global Study Institute for Climate and Society found that measured amounts of wind and dust can be utilised to predict some of the yearly variability in meningitis outbreaks, at both nationwide and district levels.

“We’ve recognized that the disease is associated to climate and environmental problems for a extended time, due to the fact it really is quite seasonal,” explained Carlos Pérez García-Pando, one of the report’s lead authors.

The challenge, he said, was to figure out which climate factors have been essential in buy to greater equip public wellness selection-makers to act.

“The idea was to try to use designs and observations from satellites and all kinds of data on possible (climate-connected) parameters that might be affecting the ailment, and consider to use that data to provide advance warning,” Pérez said.

What the group of researchers found was a notably shut correlation in between wind and dust levels and meningitis outbreaks.

Madeleine Thomson, another researcher concerned in the task, named the strength of the romantic relationship astonishing.

“A lot of professionals have known for a prolonged time that setting is crucial, but not how important,” she stated.

The analysis on meningitis follows equivalent perform with malaria, connecting climate aspects to the mosquito-borne condition.

Thomson explained that the distinctions in between the two illnesses produced them effectively-suited for comparative scientific studies.

“We had some experience working on malaria, and chose to function on meningitis, because it truly is an essential ailment, specifically for the Sahel area in Africa, and it is a dry season condition, as an alternative of a moist season ailment … So it permitted us to investigate some of the issues of dealing with a diverse sort of the condition, but again with environmental and climate elements.”

“What we have realized is that yes, this strategy can be utilized to climate sensitive illnesses, writ huge,” she said.

The researchers stated their operate was made to assist wellness officials make successful decisions about meningitis vaccination campaigns. “We have been collaborating extremely closely with decision makers,” extra Pérez.

The following actions are to increase the investigation outdoors of Niger and build models for other elements of the affected area, he explained.

“What we’ve developed is a valuable tool that can assist selection makers to think, organise, distribute medicine, and make their choices much more in advance,” Pérez said.

Sahel meningitis outbreaks linked to wind and dust ranges, declare scientists

Meningitis B vaccine set to be produced obtainable for babies in Government adviser U-flip

“The JCVI has suggested including the vaccination to the primary childhood programme, which means that, if strategies progress, infants will be immunised starting at two months of age.

”The JCVI has also suggested that the vaccine is even more extended to 3 and four-month-olds as a a single-off catch-up programme when it is launched.”

Deputy chief health care officer Professor John Watson said: ”Infants under one particular yr of age are most at chance of meningitis B and the number of circumstances peak at about 5 or six months of age.

”With early diagnosis and antibiotic remedy, most make a complete recovery. But it is fatal in about 1 in ten situations and can lead to extended-phrase wellness troubles such as amputation, deafness, epilepsy and understanding difficulties.

”We will now be functioning closely with Novartis in the coming months and, if negotiations are profitable, we hope to perform with the other United kingdom well being departments to introduce a vaccine to avoid meningitis B as quickly as attainable. This would make the Uk the 1st nation in the globe to put into action a nationwide vaccination programme.”

The JCVI at first rejected the vaccine’s use on the NHS, saying it was not a price-effective use of resources.

But much more than a hundred health-related scientists and researchers wrote to Mr Hunt telling him it was “crucial the JCVI’s interim conclusions are re-evaluated”.

Considering that then, other authorities and a public petition calling for the vaccine to be launched have additional to the strain dealing with the JCVI and Mr Hunt.

Around 1,870 individuals are estimated to contract meningitis B each and every yr in the United kingdom.

The Bexsero vaccine, authorized by the European Medicines Company much more than a 12 months in the past, is estimated to cover all around 88% of meningitis B illness.

Until now, vaccines have only protected against some other bacterial varieties of meningitis.

Meningitis B is a extremely aggressive strain of the disease which infects the protective membranes surrounding the brain and spinal cord.

It is a health care emergency and, if left untreated, can result in extreme brain injury and septicaemia. It can show fatal.

1 in 3 survivors will be left with debilitating soon after-effects such as reduction of limbs or brain harm.

Meningitis B is most common in youngsters underneath 5 and, in certain, babies beneath the age of one.

Preliminary indicators and signs in babies and kids contain a high fever with cold hands and feet, feeling agitated and not wanting to be touched, steady crying or excessive sleepiness and issues in waking.

Children could also appear confused and unresponsive. A key – and late-stage – warning indicator is a blotchy red rash that does not fade when a glass is rolled over it.

Steve Dayman, founder of the charity Meningitis Now, whose child son Spencer died from meningitis B in 1982, stated right now: “This is the most monumental announcement in the battle towards the disease in the 31 years I have campaigned to eradicate meningitis.

“It is the determination we’ve pushed for, to have the meningitis B vaccine offered cost-free to all infants.

“There is no doubt that it will conserve 1000′s of lives and spare survivors and their households the soreness of residing with lifestyle-modifying right after-effects.

“We thank our supporters for their established campaigning and the JCVI for listening to our arguments on the accurate burden of this illness.”

Earlier this 12 months, a Mumsnet survey of far more than one,000 mothers for Meningitis Now located that two-thirds of parents could not afford the jab privately but 95% have been in favour of it becoming launched on the NHS.

Professor Andrew Pollard, chairman of the JCVI and professor of paediatric infection and immunity at the University of Oxford, mentioned: “Meningitis B disproportionately influences infants and younger youngsters and can be devastating.

“After quite cautious consideration, JCVI concluded that use of the new vaccine would decrease situations of meningococcal meningitis and septicaemia and lead to a reduction in deaths, limb amputations and brain injury brought on by the ailment.

“Today the JCVI published its recommendation to the United kingdom wellness departments that if the new vaccine can be purchased at a lower price and is for that reason value-effective for the NHS, it must be employed in the routine immunisation programme for babies in the Uk to avert disease.”

Christopher Head, chief executive of the Meningitis Study Foundation, explained: “We are delighted that the JCVI have advised vaccinating all infants towards this most feared and deadly condition.

“It is a fantastic outcome which will save lives and spare numerous families the trauma of seeing a loved one particular critically disabled by the devastating right after-effects of meningitis B.

“We shell out tribute to the men and women who have suffered from this illness, whose bitter encounter has aided show the compelling situation for prevention.”

Dr Helen Bedford, senior lecturer in children’s wellness at the Institute of Child Overall health, University College London, stated: “Meningococcal B disease is extremely severe. It leads to meningitis and septicaemia, which can result in death or long-term disability. Obviously its prevention is very desirable and the vaccine would be welcomed by parents and health experts alike.”

Dr David Elliman, immunisation professional at the Royal School of Paediatrics and Little one Wellness, explained: “The JCVI has advisable the introduction of the meningococcal vaccine for schedule use in infants, if it can be obtained at a price that is cost-effective.

“If this condition can be met, which we hope will take place soon, the selection will be universally welcomed. Children’s lives will be saved and some children will be spared serious preventable disability.”

Final July’s statement from the JCVI, which is an independent adviser to the Division of Health, called for more specifics on the vaccine’s effectiveness.

It explained: “The JCVI concluded that, on the basis of the offered evidence, schedule infant or toddler immunisation utilizing Bexsero is highly unlikely to be value-efficient at any vaccine price tag primarily based on the accepted threshold for cost- effectiveness utilized in the Uk and could not be suggested.

“Similarly, if the vaccine had little or no influence on the acquisition of meningococcal carriage, adolescent immunisation is also extremely unlikely to be expense-effective at any vaccine price.”

In October, it issued a further statement saying it was thinking about new proof and the views of charities.

Professor Andrew Pollard, chairman of JCVI, mentioned at the time: “We are seeking quite carefully at the new details and perspectives that have been offered to us by scientists, the meningitis charities and the producers to guarantee that we use the best obtainable evidence to advise the Uk wellness departments on the prospective of a vaccine.”

Meningitis B vaccine set to be produced obtainable for babies in Government adviser U-flip

Meningitis B vaccine set to be created accessible for babies in Government U-flip

“The JCVI has advised including the vaccination to the major childhood programme, which means that, if strategies progress, infants will be immunised commencing at two months of age.

”The JCVI has also recommended that the vaccine is even more extended to three and 4-month-olds as a a single-off catch-up programme when it is introduced.”

Deputy chief healthcare officer Professor John Watson mentioned: ”Infants below one 12 months of age are most at chance of meningitis B and the number of circumstances peak at close to 5 or six months of age.

”With early diagnosis and antibiotic remedy, most make a complete recovery. But it is fatal in about one in ten instances and can lead to lengthy-term wellness troubles this kind of as amputation, deafness, epilepsy and studying troubles.

”We will now be functioning closely with Novartis in the coming months and, if negotiations are productive, we hope to perform with the other United kingdom well being departments to introduce a vaccine to stop meningitis B as swiftly as possible. This would make the Uk the initial country in the planet to apply a nationwide vaccination programme.”

The JCVI at first rejected the vaccine’s use on the NHS, saying it was not a price-powerful use of resources.

But a lot more than 100 healthcare scientists and researchers wrote to Mr Hunt telling him it was”vital the JCVI’s interim conclusions are re-evaluated”.

Since then, other experts and a public petition calling for the vaccine to be introduced have additional to the stress dealing with the JCVI and Mr Hunt.

Around 1,870 people are estimated to contract meningitis B each year in the United kingdom.

The Bexsero vaccine, approved by the European Medicines Company much more than a year ago, is estimated to cover around 88% of meningitis B illness.

Right up until now, vaccines have only protected against some other bacterial kinds of meningitis.

Meningitis B is a very aggressive strain of the condition which infects the protective membranes surrounding the brain and spinal cord.

It is a health-related emergency and, if left untreated, can cause serious brain harm and septicaemia. It can prove fatal.

A single in 3 survivors will be left with debilitating soon after-effects such as loss of limbs or brain harm.

Meningitis B is most common in young children beneath 5 and, in certain, babies underneath the age of one particular.

Preliminary signs and symptoms in infants and children contain a higher fever with cold hands and feet, feeling agitated and not wanting to be touched, continuous crying or extreme sleepiness and trouble in waking.

Kids might also appear puzzled and unresponsive. A main – and late-stage – warning indicator is a blotchy red rash that does not fade when a glass is rolled over it.

Steve Dayman, founder of the charity Meningitis Now, whose infant son Spencer died from meningitis B in 1982, said today: “This is the most monumental announcement in the fight towards the condition in the 31 many years I have campaigned to eradicate meningitis.

“It is the choice we’ve pushed for, to have the meningitis B vaccine given free of charge to all infants.

“There is no doubt that it will save 1000′s of lives and spare survivors and their households the discomfort of residing with life-shifting after-results.

“We thank our supporters for their determined campaigning and the JCVI for listening to our arguments on the true burden of this illness.”

Earlier this 12 months, a Mumsnet survey of a lot more than 1,000 mothers for Meningitis Now discovered that two-thirds of parents could not afford the jab privately but 95% had been in favour of it being introduced on the NHS.

Professor Andrew Pollard, chairman of the JCVI and professor of paediatric infection and immunity at the University of Oxford, explained: “Meningitis B disproportionately influences infants and young children and can be devastating.

“Right after really cautious consideration, JCVI concluded that use of the new vaccine would decrease cases of meningococcal meningitis and septicaemia and lead to a reduction in deaths, limb amputations and brain damage caused by the ailment.

“Right now the JCVI published its recommendation to the United kingdom wellness departments that if the new vaccine can be obtained at a minimal cost and is therefore value-effective for the NHS, it must be utilised in the regimen immunisation programme for babies in the Uk to stop condition.”

Christopher Head, chief executive of the Meningitis Study Basis, stated: “We are delighted that the JCVI have recommended vaccinating all babies against this most feared and deadly ailment.

“It’s a superb outcome which will conserve lives and spare a great number of households the trauma of seeing a loved one particular significantly disabled by the devastating after-results of meningitis B.

“We pay tribute to the individuals who have suffered from this illness, whose bitter encounter has aided demonstrate the compelling case for prevention.”

Dr Helen Bedford, senior lecturer in children’s wellness at the Institute of Little one Wellness, University College London, said: “Meningococcal B disease is extremely serious. It brings about meningitis and septicaemia, which can result in death or extended-phrase disability. Obviously its prevention is very desirable and the vaccine would be welcomed by dad and mom and well being professionals alike.”

Dr David Elliman, immunisation skilled at the Royal College of Paediatrics and Child Health, explained: “The JCVI has recommended the introduction of the meningococcal vaccine for routine use in infants, if it can be obtained at a price that is expense-successful.

“If this problem can be met, which we hope will come about soon, the choice will be universally welcomed. Children’s lives will be saved and some young children will be spared significant preventable disability.”

Meningitis B vaccine set to be created accessible for babies in Government U-flip

New vaccine towards meningitis B set to be created obtainable on NHS

Sources shut to Jeremy Hunt explained the JCVI had noted the criticisms of its selection on Bexsero and had reversed its conclusions. Photograph: Jack Taylor/Barcroft Media

A new vaccine towards the deadly illness meningitis B is set be made offered free on the NHS. The Division of Health explained that it would make an announcement on Friday morning.

The Bexsero therapy was licensed in Europe in January last yr but the NHS had previously been advised towards adopting it due to a lack of proof of its effectiveness.

Meningitis B, which is most common in young children under five years outdated, especially in babies beneath the age of 1, is a hugely aggressive strain of bacterial meningitis. It infects the protective membranes surrounding the brain and spinal cord and can cause serious brain damage, septicaemia or even death.

Of the estimated one,870 cases of meningitis B every single yr in the Uk about one particular in 10 folks impacted will die and 1 in three will be left with debilitating after-results this kind of as loss of limbs or brain damage, in accordance to campaigners.

The Meningitis Now charity has campaigned for the Bexsero vaccine to be offered on the NHS in the hope of conserving 1000′s of lives and sparing numerous from life-altering following-results.

About 200 scientists and researchers backed a petition final month calling meningitis and meningococcal condition “a parent’s biggest worry” and calling for swift reappraisal of the recommendation made by the independent Joint Committee on Vaccination and Immunisation (JCVI), which advises the government on vaccinations.

In accordance to the Independent, sources shut to the overall health secretary, Jeremy Hunt, said the JCVI had mentioned the criticisms of its determination by top medical researchers and medical professionals and had now reversed its conclusion that the vaccine was not price-efficient.

New vaccine towards meningitis B set to be created obtainable on NHS

Meningitis vaccine withstands African heat without having injury

A little one becoming vaccinated against meningitis in Niger. The trial targeted 155,000 individuals across 150 villages in rural Benin. Photograph: AFP/Getty

The initial immunisation campaign in Africa making use of a vaccine that does not have to be stored in fridges and iceboxes has been productive and considerably cut charges, in accordance to scientists.

MenAfriVac is authorised for use at temperatures not exceeding 40C and can be stored out of the fridge for up to four days. The vaccine towards meningitis A was uncommon in getting made specifically for the African meningitis belt, the place yearly epidemics employed to kill 1000′s, but professionals say it would be possible to permit other vaccines to be utilized outdoors of cold-chain situations. Vaccines towards yellow fever and cholera are among those that could potentially be stored and utilized securely at increased temperatures, enabling many a lot more men and women to be reached in remote regions and the price of immunisation campaigns to come down.

In the journal Vaccine, medical doctors report the achievement of a trial in Benin of MenAfriVac at controlled temperatures under 40C, rather than the 2C-8C that is normal for vaccines. Component of the population was given the vaccine from the regular cold chain – stored in fridges, moved about the country in refrigerated vehicles and taken into the field in great boxes containing icepacks. The rest had been provided MenAfriVac that had been out of the fridge for up to 4 days. Neither group had a situation of meningitis A, and the vaccine remained viable at temperatures as large as 39C.

MenAfriVac was created by the World Wellness Organisation (WHO) and Path, a non-profit international wellness group. The vaccine is manufactured by the Serum Institute of India and it was the Indian regulatory authorities who gave approval for its use outside of cold situations. The query is whether or not companies of other vaccines that are also used in affluent nations, in which electricity and refrigeration are not a issue, will seek out equivalent approval.

A paper published in the WHO’s Bulletin demonstrated that not having to refrigerate MenAfriVac would have lower the fees of immunisation in Chad by 50%. “The remarkable coverage we noticed in Benin when MenAfriVac was utilized outside of the cold chain paves the way for potential campaigns in other regions with demanding geography, like countries exactly where the vaccine will be administered later on this yr to rural populations living in the desert,” stated Dr Marie-Pierre Préziosi, director of the Meningitis Vaccine Venture, the collaboration amongst WHO and Path that drove the advancement of MenAfriVac.

The trial targeted the rural Benin district of Banikoara, vaccinating 155,000 people across 150 villages. Only nine vaccine vials had been discarded since they had been at typical temperatures for a lot more than four days. None had to be discarded since of getting been exposed to temperatures of 40C or far more – a particular heat-sensitive sticker modified colour as a warning if that occurred.

Much more than 150 million individuals in the African meningitis belt have been vaccinated with MenAfriVac considering that it was launched in 2010. No situation of meningitis A has been recognized in those vaccinated.

Meningitis vaccine withstands African heat without having injury

British Lung Foundation: smoking in automobiles "could lead to meningitis" in young children

The Commons will vote on regardless of whether to give the well being secretary the power to impose a ban on smoking in vehicles, regardless of the opposition of some MPs such as members of the Cabinet.

Steven Wibberley from the British Lung Basis explained the health implications of smoking in automobiles.

“Because it is an enclosed surroundings, it concentrates the smoke and the toxins in that smoke and due to the fact kids have received modest underdeveloped lungs, that has a genuine effect on their wellness.”

“It prospects to things like asthma, chest infections, ear infections, but also even items like meningitis.”

Downing Street has confirmed that Prime Minister would miss the vote, as he is staying in the South West overnight to pay a visit to areas impacted by flooding, but indicated that he believes “the time has come” for a ban on smoking in cars containing children.

British Lung Foundation: smoking in automobiles "could lead to meningitis" in young children

British Lung Basis: smoking in cars "could lead to meningitis" in kids

The Commons will vote on whether to give the well being secretary the power to impose a ban on smoking in vehicles, despite the opposition of some MPs like members of the Cabinet.

Steven Wibberley from the British Lung Foundation explained the overall health implications of smoking in automobiles.

“Simply because it truly is an enclosed environment, it concentrates the smoke and the toxins in that smoke and due to the fact children have got modest underdeveloped lungs, that has a true impact on their overall health.”

“It leads to factors like asthma, chest infections, ear infections, but also even factors like meningitis.”

Downing Street has confirmed that Prime Minister would miss the vote, as he is staying in the South West overnight to pay a visit to locations impacted by flooding, but indicated that he believes “the time has come” for a ban on smoking in vehicles containing young children.

British Lung Basis: smoking in cars "could lead to meningitis" in kids